202 related articles for article (PubMed ID: 6696702)
1. Side effects of antimotion sickness drugs.
Wood CD; Manno JE; Manno BR; Redetzki HM; Wood M; Vekovius WA
Aviat Space Environ Med; 1984 Feb; 55(2):113-6. PubMed ID: 6696702
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of antimotion sickness drug side effects on performance.
Wood CD; Manno JE; Manno BR; Redetzki HM; Wood MJ; Mims ME
Aviat Space Environ Med; 1985 Apr; 56(4):310-6. PubMed ID: 3888169
[TBL] [Abstract][Full Text] [Related]
3. Effects of some motion sickness suppressants on static and dynamic tracking performance.
Schroeder DJ; Collins WE; Elam GW
Aviat Space Environ Med; 1985 Apr; 56(4):344-50. PubMed ID: 3994616
[TBL] [Abstract][Full Text] [Related]
4. Motion-sickness medications for aircrew: impact on psychomotor performance.
Paul MA; MacLellan M; Gray G
Aviat Space Environ Med; 2005 Jun; 76(6):560-5. PubMed ID: 15945400
[TBL] [Abstract][Full Text] [Related]
5. Prevention of experimental motion sickness by scopolamine absorbed through the skin.
Graybiel A; Knepton J; Shaw J
Aviat Space Environ Med; 1976 Oct; 47(10):1096-100. PubMed ID: 791234
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of antimotion sickness drugs.
Wood CD; Manno JE; Wood MJ; Manno BR; Redetzki HM
Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A262-5. PubMed ID: 3675502
[TBL] [Abstract][Full Text] [Related]
7. The effect of antimotion sickness drugs on habituation to motion.
Wood CD; Manno JE; Manno BR; Odenheimer RC; Bairnsfather LE
Aviat Space Environ Med; 1986 Jun; 57(6):539-42. PubMed ID: 3718377
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness.
Wood CD; Stewart JJ; Wood MJ; Manno JE; Manno BR; Mims ME
Aviat Space Environ Med; 1990 Feb; 61(2):157-61. PubMed ID: 2178599
[TBL] [Abstract][Full Text] [Related]
9. Promethazine as a motion sickness treatment: impact on human performance and mood states.
Cowings PS; Toscano WB; DeRoshia C; Miller NE
Aviat Space Environ Med; 2000 Oct; 71(10):1013-22. PubMed ID: 11051308
[TBL] [Abstract][Full Text] [Related]
10. Effects of scopolamine and dextroamphetamine on human performance.
Schmedtje JF; Oman CM; Letz R; Baker EL
Aviat Space Environ Med; 1988 May; 59(5):407-10. PubMed ID: 3390096
[TBL] [Abstract][Full Text] [Related]
11. A comparison of some effects of three antimotion sickness drugs on nystagmic responses to angular accelerations and to optokinetic stimuli.
Collins WE; Schroeder DJ; Elam GW
Aviat Space Environ Med; 1982 Dec; 53(12):1182-9. PubMed ID: 7159338
[TBL] [Abstract][Full Text] [Related]
12. Comparison of efficacy of ginger with various antimotion sickness drugs.
Wood CD; Manno JE; Wood MJ; Manno BR; Mims ME
Clin Res Pr Drug Regul Aff; 1988; 6(2):129-36. PubMed ID: 11538042
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological interventions for motion sickness: cardiovascular effects.
Sunahara FA; Farewell J; Mintz L; Johnson WH
Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A270-6. PubMed ID: 3499896
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of scopolamine and amphetamine on microcomputer-based performance tests.
Kennedy RS; Odenheimer RC; Baltzley DR; Dunlap WP; Wood CD
Aviat Space Environ Med; 1990 Jul; 61(7):615-21. PubMed ID: 2386447
[TBL] [Abstract][Full Text] [Related]
15. Comparison of treatment strategies for Space Motion Sickness.
Davis JR; Jennings RT; Beck BG
Microgravity Q; 1992 Jul; 2(3):173-7. PubMed ID: 11541442
[TBL] [Abstract][Full Text] [Related]
16. Autogenic-feedback training exercise is superior to promethazine for control of motion sickness symptoms.
Cowings PS; Toscano WB
J Clin Pharmacol; 2000 Oct; 40(10):1154-65. PubMed ID: 11028255
[TBL] [Abstract][Full Text] [Related]
17. Investigation of anti-motion sickness drugs in the squirrel monkey.
Cheung BS; Money KE; Kohl RL; Kinter LB
J Clin Pharmacol; 1992 Feb; 32(2):163-75. PubMed ID: 1613127
[TBL] [Abstract][Full Text] [Related]
18. Human assay of antimotion sickness drugs.
Graybiel A; Wood CD; Knepton J; Hoche JP; Perkins GF
Aviat Space Environ Med; 1975 Sep; 46(9):1107-18. PubMed ID: 1100039
[TBL] [Abstract][Full Text] [Related]
19. Relative efficacy of the proposed Space Shuttle antimotion sickness medications.
Hordinsky JR; Schwartz E; Beier J; Martin J; Aust G
Acta Astronaut; 1982; 9(6-7):375-83. PubMed ID: 11541691
[TBL] [Abstract][Full Text] [Related]
20. Treatment efficacy of intramuscular promethazine for space motion sickness.
Davis JR; Jennings RT; Beck BG; Bagian JP
Aviat Space Environ Med; 1993 Mar; 64(3 Pt 1):230-3. PubMed ID: 8447805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
